Literature DB >> 21419609

Effect of Cystone® on urinary composition and stone formation over a one year period.

S B Erickson1, T J Vrtiska, J C Lieske.   

Abstract

Kidney stones are a common problem for which inadequate prevention exists. We recruited ten recurrent kidney stone formers with documented calcium oxalate stones into a two phased study to assess safety and effectiveness of Cystone(®), an herbal treatment for prevention of kidney stones. The first phase was a randomized double-blinded 12 week cross over study assessing the effect of Cystone(®) vs. placebo on urinary supersaturation. The second phase was an open label one year study of Cystone(®) to determine if renal stone burden decreased, as assessed by quantitative and subjective assessment of CT. Results revealed no statistically significant effect of Cystone(®) on urinary composition short (6 weeks) or long (52 weeks) term. Average renal stone burden increased rather than decreased on Cystone(®). Therefore, this study does not support the efficacy of Cystone(®) to treat calcium oxalate stone formers. Future studies will be needed to assess effects on stone passage, or on other stone types.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419609      PMCID: PMC3925635          DOI: 10.1016/j.phymed.2011.01.018

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  21 in total

1.  Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion.

Authors:  F Grases; J G March; R M Prieto; B M Simonet; A Costa-Bauzá; A García-Raja; A Conte
Journal:  Scand J Urol Nephrol       Date:  2000-06

2.  Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.

Authors:  Allen Rodgers; Shameez Allie-Hamdulay; Graham Jackson
Journal:  Nephrol Dial Transplant       Date:  2005-10-25       Impact factor: 5.992

Review 3.  Medical therapy to facilitate urinary stone passage: a meta-analysis.

Authors:  John M Hollingsworth; Mary A M Rogers; Samuel R Kaufman; Timothy J Bradford; Sanjay Saint; John T Wei; Brent K Hollenbeck
Journal:  Lancet       Date:  2006-09-30       Impact factor: 79.321

4.  Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures.

Authors:  M R Sowers; M Jannausch; C Wood; S K Pope; L L Lachance; B Peterson
Journal:  Am J Epidemiol       Date:  1998-05-15       Impact factor: 4.897

5.  Phyllanthus niruri inhibits calcium oxalate endocytosis by renal tubular cells: its role in urolithiasis.

Authors:  A H Campos; N Schor
Journal:  Nephron       Date:  1999       Impact factor: 2.847

6.  The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model.

Authors:  T Yasui; K Fujita; M Sato; M Sugimoto; M Iguchi; S Nomura; K Kohri
Journal:  Urol Res       Date:  1999-06

7.  Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers.

Authors:  Vivek Kumar; Lourdes Peña de la Vega; Gerard Farell; John C Lieske
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

8.  Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?

Authors:  Christopher S Saigal; Geoffrey Joyce; Anga R Timilsina
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

9.  Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.

Authors:  B Ettinger; C Y Pak; J T Citron; C Thomas; B Adams-Huet; A Vangessel
Journal:  J Urol       Date:  1997-12       Impact factor: 7.450

10.  Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.

Authors:  J L Nishiura; A H Campos; M A Boim; I P Heilberg; N Schor
Journal:  Urol Res       Date:  2004-06-19
View more
  4 in total

1.  The protective effects of an herbal agent tutukon on ethylene glycol and zinc disk induced urolithiasis model in a rat model.

Authors:  Emrah Yuruk; Murat Tuken; Cahit Sahin; Asuman Orcun Kaptanagasi; Kayhan Basak; Serdar Aykan; Ahmet Yaser Muslumanoglu; Kemal Sarica
Journal:  Urolithiasis       Date:  2016-05-09       Impact factor: 3.436

2.  Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers.

Authors:  Stephen B Erickson; Terri J Vrtiska; Vincent J Canzanello; John C Lieske
Journal:  Urol Res       Date:  2010-12-16

3.  Efficacy of Ficus tikoua Bur. extract in ethylene glycol-induced urolithiasis model in SD rats.

Authors:  Arina V Bervinova; Viktor A Palikov; Evgeny S Mikhailov; Yulia A Palikova; Natalya A Borozdina; Vitaly A Kazakov; Pavel A Rudenko; Elena A Tukhovskaya; Igor A Dyachenko; Gulsara A Slashcheva; Natalya A Goryacheva; Elena S Sadovnikova; Irina N Kravchenko; Elena A Kalabina; Maksim V Shinelev; Peng Wu; Arkady N Murashev
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

4.  Compound Characterization and Metabolic Profile Elucidation after In Vitro Gastrointestinal and Hepatic Biotransformation of an Herniaria hirsuta Extract Using Unbiased Dynamic Metabolomic Data Analysis.

Authors:  Laura Peeters; Anastasia Van der Auwera; Charlie Beirnaert; Sebastiaan Bijttebier; Kris Laukens; Luc Pieters; Nina Hermans; Kenn Foubert
Journal:  Metabolites       Date:  2020-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.